LMR Partners’s Neuronetics STIM Stock Holding History

LMR Partners’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,922	Closed	-$135K	–	1313
2021 Q1	$135K	Buy	+10,922	New	+$167K	﹤0.01%	830

Other funds holding STIM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

LMR Partners's STIM Position: Q2 2021 in Review

LMR Partners sold out of Neuronetics (STIM) in Q2 2021, closing a stake of 10,922 shares — an estimated $135K sold.

LMR Partners first reported a position in STIM in Q1 2021 and held it in 1 quarter. The position peaked at $135K in Q1 2021. 105 funds tracked by Wall St. Rank hold STIM as of Q2 2021.

LMR Partners reported no remaining Neuronetics position as of Q2 2021 after selling out during the quarter.
LMR Partners sold 10,922 Neuronetics shares in Q2 2021, an estimated $135K.
LMR Partners first reported a position in Neuronetics in Q1 2021 and held it in 1 quarter.
LMR Partners's Neuronetics position peaked at $135K in Q1 2021.
105 funds tracked by Wall St. Rank held Neuronetics as of Q2 2021.

Based on LMR Partners's 13F filing for Q2 2021, filed 16 Aug 2021.